After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARDX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Ardelyx Inc is $1.57B. A total of 3.44 million shares were traded on the day, compared to an average of 4.38M shares.
In the most recent transaction, Williams Laura A sold 80,000 shares of ARDX for 6.12 per share on Aug 26 ’25. After the transaction, the Chief Patient Officer now owns 366,322 company shares. In a previous transaction on Aug 21 ’25, Kelliher Mike sold 5,417 shares at 5.93 per share. ARDX shares that Chief Business Officer owns now total 276,741.
Among the insiders who bought shares, LAURA A WILLIAMS acquired of 80,000 shares on Aug 26 ’25 at a per-share price of $6.06. In another insider transaction, Williams Laura A sold 6,261 shares at $5.93 per share on Aug 21 ’25. Company shares held by the Chief Patient Officer now total 396,322.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARDX has a high of $7.18 and a low of $3.21.
As of this writing, ARDX has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.13. The company reported an EPS of $0 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARDX’s latest balance sheet shows that the firm has $116.69M in Cash & Short Term Investments as of fiscal 2021. There were $45.50M in debt and $52.82M in liabilities at the time. Its Book Value Per Share was $0.58, while its Total Shareholder’s Equity was $82.62M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARDX is Buy with a score of 4.62.
